Baidu
map

J Endod:应用于牙髓再生中的不同阻射双抗糊剂的阻射性及抗菌性评估

2018-08-20 lishiting MedSci原创

这篇研究的目的是为了评估包含硫酸钡(BaSO4)或氧化锆(ZrO2)造影剂的不同浓度双抗糊剂(DAP)的阻射性及抗菌性。

这篇研究的目的是为了评估包含硫酸钡(BaSO4)或氧化锆(ZrO2)造影剂的不同浓度双抗糊剂(DAP)的阻射性及抗菌性。

研究按照ISO 6876/2001的标准略微修改后(n = 6 per group)比较和检测包含30% (w/v) BaSO4或ZrO2的1, 10和25 mg/mL DAP、不含DAP的阻射糊剂和商品化阻射性氢氧化钙(Ca[OH]2)的阻射性能。从牙髓坏死的未成熟牙齿牙根中获取菌斑生物膜在厌氧环境下感染牙本质样本(n = 70) 3周,施以相似的实验性糊剂或不加干预。1周后,将糊剂清洗干净后进行生物膜破裂评估。为了检测剩余抗菌效果,无菌牙本质样本(n = 70)应用同样的糊剂预处理1周(n = 7)。将糊剂清洗干净,样本浸入磷酸盐缓冲液中24小时,在厌氧环境下用相同的菌斑生物膜感染3周后进行生物膜破裂评估。使用无菌牙本质块作为2次抗菌试验的阴性对照(n = 7)。采用Wilcoxon rank sum检验进行统计学评估。

结果显示,不同浓度BaSO4 DAP或ZrO2 DAP与Ca(OH)2的阻射性相比没有显著性差异。然而,所有测试浓度BaSO4 DAP, ZrO2 DAP和Ca(OH)2均展现出直接的抗菌作用。1 mg/mL的 ZrO2 DAP和Ca(OH)2没有明显的剩余抗菌作用。

结论:1 mg/mL的BaSO4 DAP具有明显较强的剩余抗菌作用以及堪比商品化Ca(OH)2的阻射性能。

原始出处:

Verma R, Fischer BI, et al. The Radiopacity and Antimicrobial Properties of Different Radiopaque Double Antibiotic Pastes Used in Regenerative Endodontics. J Endod. 2018 Aug 2. pii: S0099-2399(18)30437-0. doi: 10.1016/j.joen.2018.06.010.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1669692, encodeId=be621669692e3, content=<a href='/topic/show?id=c7ca6e660ab' target=_blank style='color:#2F92EE;'>#牙髓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67660, encryptionId=c7ca6e660ab, topicName=牙髓)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5eeb26562774, createdName=jxrzshh, createdTime=Sat Jan 26 03:12:00 CST 2019, time=2019-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330765, encodeId=7d881330e65a1, content=<a href='/topic/show?id=c6b455688d1' target=_blank style='color:#2F92EE;'>#抗菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55688, encryptionId=c6b455688d1, topicName=抗菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Aug 22 02:12:00 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417506, encodeId=d6ee141e50622, content=<a href='/topic/show?id=84ff6e663c4' target=_blank style='color:#2F92EE;'>#牙髓再生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67663, encryptionId=84ff6e663c4, topicName=牙髓再生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0cf73291723, createdName=zhixianchen, createdTime=Wed Aug 22 02:12:00 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487234, encodeId=cdea148e234fe, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37461, encryptionId=334b3e46139, topicName=双抗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbaa8296156, createdName=yeye5224615, createdTime=Wed Aug 22 02:12:00 CST 2018, time=2018-08-22, status=1, ipAttribution=)]
    2019-01-26 jxrzshh
  2. [GetPortalCommentsPageByObjectIdResponse(id=1669692, encodeId=be621669692e3, content=<a href='/topic/show?id=c7ca6e660ab' target=_blank style='color:#2F92EE;'>#牙髓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67660, encryptionId=c7ca6e660ab, topicName=牙髓)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5eeb26562774, createdName=jxrzshh, createdTime=Sat Jan 26 03:12:00 CST 2019, time=2019-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330765, encodeId=7d881330e65a1, content=<a href='/topic/show?id=c6b455688d1' target=_blank style='color:#2F92EE;'>#抗菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55688, encryptionId=c6b455688d1, topicName=抗菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Aug 22 02:12:00 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417506, encodeId=d6ee141e50622, content=<a href='/topic/show?id=84ff6e663c4' target=_blank style='color:#2F92EE;'>#牙髓再生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67663, encryptionId=84ff6e663c4, topicName=牙髓再生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0cf73291723, createdName=zhixianchen, createdTime=Wed Aug 22 02:12:00 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487234, encodeId=cdea148e234fe, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37461, encryptionId=334b3e46139, topicName=双抗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbaa8296156, createdName=yeye5224615, createdTime=Wed Aug 22 02:12:00 CST 2018, time=2018-08-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1669692, encodeId=be621669692e3, content=<a href='/topic/show?id=c7ca6e660ab' target=_blank style='color:#2F92EE;'>#牙髓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67660, encryptionId=c7ca6e660ab, topicName=牙髓)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5eeb26562774, createdName=jxrzshh, createdTime=Sat Jan 26 03:12:00 CST 2019, time=2019-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330765, encodeId=7d881330e65a1, content=<a href='/topic/show?id=c6b455688d1' target=_blank style='color:#2F92EE;'>#抗菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55688, encryptionId=c6b455688d1, topicName=抗菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Aug 22 02:12:00 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417506, encodeId=d6ee141e50622, content=<a href='/topic/show?id=84ff6e663c4' target=_blank style='color:#2F92EE;'>#牙髓再生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67663, encryptionId=84ff6e663c4, topicName=牙髓再生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0cf73291723, createdName=zhixianchen, createdTime=Wed Aug 22 02:12:00 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487234, encodeId=cdea148e234fe, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37461, encryptionId=334b3e46139, topicName=双抗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbaa8296156, createdName=yeye5224615, createdTime=Wed Aug 22 02:12:00 CST 2018, time=2018-08-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1669692, encodeId=be621669692e3, content=<a href='/topic/show?id=c7ca6e660ab' target=_blank style='color:#2F92EE;'>#牙髓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67660, encryptionId=c7ca6e660ab, topicName=牙髓)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5eeb26562774, createdName=jxrzshh, createdTime=Sat Jan 26 03:12:00 CST 2019, time=2019-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330765, encodeId=7d881330e65a1, content=<a href='/topic/show?id=c6b455688d1' target=_blank style='color:#2F92EE;'>#抗菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55688, encryptionId=c6b455688d1, topicName=抗菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Aug 22 02:12:00 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417506, encodeId=d6ee141e50622, content=<a href='/topic/show?id=84ff6e663c4' target=_blank style='color:#2F92EE;'>#牙髓再生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67663, encryptionId=84ff6e663c4, topicName=牙髓再生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0cf73291723, createdName=zhixianchen, createdTime=Wed Aug 22 02:12:00 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487234, encodeId=cdea148e234fe, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37461, encryptionId=334b3e46139, topicName=双抗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbaa8296156, createdName=yeye5224615, createdTime=Wed Aug 22 02:12:00 CST 2018, time=2018-08-22, status=1, ipAttribution=)]
Baidu
map
Baidu
map
Baidu
map